Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
A phase 3 trial registered on ClinicalTrials.gov. The registry status is active, not recruiting. It plans to enroll 210 participants.
Also called NCT04088292
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 210 participants
- Sponsor
- Registry
-
NCT04088292
-
- Other papers using this trial's data
- Randomized trial of low-dose, ultrasound-assisted thrombolysis or heparin for pulmonary embolism
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (anticipated)
- Countries
- Denmark
- Registry status
- Active, not recruiting
Technical summary
Registry record NCT04088292. Randomized; single masking; primary purpose treatment. Start 2019-06-06 (actual); primary completion 2024-06-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Low Dose Thrombolysis, Ultrasound Assisted Thrombolysis or Heparin for Intermediate High Risk Pulmonary Embolism
- Acronym
- STRATIFY
- Condition
- Pulmonary Embolism
- Intervention (Drug)
- Alteplase 20 Mg Powder for Solution for Injection Vial
- Intervention (Device)
- Ultrasound assisted Thrombolysis
- Lead sponsor
- Copenhagen University Hospital, Rigshospitalet
- Collaborator
- Herlev and Gentofte Hospital
- Collaborator
- University Hospital Bispebjerg and Frederiksberg
- Collaborator
- Hillerod Hospital, Denmark
- Collaborator
- Copenhagen University Hospital, Hvidovre
Record details
- Record id
cardio:ct-nct04088292- Content hash
8eaf57b75cfffaed65e288d06627886e0f0b398354113717be0a6adc61dd54fb